YOUR GO-TO INTELLIGENCE RESOURCE FOR THE SCHOLARLY PUBLISHING INDUSTRY

Clarivate Plc, a global leader in connecting people and organizations to intelligence they can trust to transform their world, has launched its new enhanced search platform leveraging generative artificial intelligence (GenAI). The new Clarivate offering enables drug discovery, preclinical, clinical, regulatory affairs and portfolio strategy teams to interact with multiple complex datasets using natural language to obtain immediate and in-depth insights.

Rapid, accurate insights are challenged by a typical paradigm of disparate, siloed data sources. Many standard databases and companies have focused use cases and the ability to track scientific innovation from start to finish is complex, costly, and inefficient. The new Clarivate enhanced search platform addresses these obstacles by pairing billions of proprietary data points and over 100 years of deep industry and domain expertise with GenAI capabilities. By integrating vast content sets and analytics from solutions, including Cortellis Competitive Intelligence^™, Disease Landscape & Forecast^™ and Drug Timelines and Success Rates (DTSR) into the new interactive platform, users can access harmonized data featuring precise, concise and immediate answers to the life science industry’s most urgent questions.

Researchers can access and interrogate epidemiologic, scientific, clinical, commercial and research data within one platform to overcome barriers to enabling evidence-based decisions and complex analyses. Derived from advanced GenAI and data science techniques that algorithmically process high-value curated content, users can identify companies developing breakthrough therapies, anticipate medical advancements and understand market dynamics, essential for the advancement of bringing new therapies to market.

Additional features and functionalities include among others: Natural Language: Users can input questions using natural language for an effortless search experience; Multi –faceted insights: Leverage proprietary Knowledge Graph and non-relational databases combined with patent pending traditional and GenAI data science methods to integrate systems and unlock data connections; Intelligent Summarization: Users can access clear and concise summarizations featuring the most relevant insights leveraging its built-in knowledgebase of life sciences and healthcare; Clear results: Data results are highlighted in dedicated sections for ease of interpretation, analysis and review of insights, avoiding hallucinations common to GenAI models; and Continuous learning: Customers can benefit from adaptive learning and constant improvement for consistently accurate results. On-going user feedback, advancements in features and algorithms, and the continuous integration of datasets will allow for the delivery of new and unique insights.

The beta version of the enhanced search platform has been launched with select customers to optimize the platform for use by broader audiences by discovering new use cases, exploring UI / UX capabilities, obtaining and incorporating feedback and previewing new features and functionality. Commercialization is anticipated later this year, with plans to extend the knowledge base by integrating additional datasets from solutions, including: Cortellis Clinical Trials Intelligence^™, Cortellis Deals Intelligence^™, OFF-X^™ Safety Intelligence, Cortellis Drug Discovery Intelligence^™, Cortellis Regulatory Intelligence^™ and others. Clarivate will continue to evolve the platform with technical enhancements, heightened search capabilities, data mapping and AI model updates in the near term.